| 000 | 01910 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517081641.0 | ||
| 264 | 0 | _c20170223 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkw005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCastillo-Mancilla, Jose R | |
| 245 | 0 | 0 |
_aPharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342). _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _c06 2016 |
||
| 300 |
_a1609-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAtazanavir Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHIV Protease Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeru |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSouth Africa |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAquilante, Christina L | |
| 700 | 1 | _aWempe, Michael F | |
| 700 | 1 | _aSmeaton, Laura M | |
| 700 | 1 | _aFirnhaber, Cynthia | |
| 700 | 1 | _aLaRosa, Alberto M | |
| 700 | 1 | _aKumarasamy, Nagalingeswaran | |
| 700 | 1 | _aAndrade, Adriana | |
| 700 | 1 | _aBaheti, Gautam | |
| 700 | 1 | _aFletcher, Courtney V | |
| 700 | 1 | _aCampbell, Thomas B | |
| 700 | 1 | _aHaas, David W | |
| 700 | 1 | _aMaWhinney, Samantha | |
| 700 | 1 | _aAnderson, Peter L | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 71 _gno. 6 _gp. 1609-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkw005 _zAvailable from publisher's website |
| 999 |
_c25748171 _d25748171 |
||